Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer Research

• Publication date

  1997-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9331094
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.

  1997cited by this paper
• Glioma Cells Transduced with an Escherichia coli CD/HSV-1 TK Fusion Gene Exhibit Enhanced Metabolic Suicide and Radiosensitivity

  1997cited by this paper
• Regional Delivery of an Adenovirus Vector Containing the Escherichia coli Cytosine Deaminase Gene to Provide Local Activation of 5-Fluorocytosine to Suppress the Growth of Colon Carcinoma Metastatic to Liver

  1996cited by this paper
• Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.

  1996cited by this paper
• Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir.

  1996cited by this paper
• A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma.

  1996cited by this paper
• Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma.

  1996cited by this paper
• Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer

  1996cited by this paper
• In vivo gene transfer to the human biliary tract.

  1996cited by this paper
• Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity.

  1996cited by this paper
• Radiosensitizing nucleosides.

  1996cited by this paper
• Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene.

  1996cited by this paper
• Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapy.

  1996cited by this paper
• In situ use of suicide genes for cancer therapy.

  1996cited by this paper
• Cytosine Deaminase Gene as a Positive Selection Marker (*)

  1996cited by this paper
• Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy

  1995cited by this paper
• Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.

  1995cited by this paper
• Combination gene therapy for liver metastasis of colon carcinoma in vivo.

  1995cited by this paper
• Technique of inserting multiple biliary drains and management.

  1995cited by this paper
• Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.

  1995cited by this paper
• Malignancies of the biliary tree.

  1995cited by this paper
• Perihilar Cholangiocarcinoma Postoperative Radiotherapy Does Not Improve Survival

  1995cited by this paper
• Transcriptional Regulatory Sequences of Carcinoembryonic Antigen: Identification and Use with Cytosine Deaminase for Tumor-Specific Gene Therapy

  1995cited by this paper
• Modification of the radiosensitivity of human cells to which simian virus 40 T-antigen was transfected.

  1995cited by this paper
• Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.

  1995cited by this paper
• Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.

  1995cited by this paper
• Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.

  1994cited by this paper
• Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.

  1994cited by this paper
• Metabolic suicide genes in gene therapy.

  1994cited by this paper
• Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene.

  1994cited by this paper
• Use of recombinant adenovirus for metabolic engineering of mammalian cells.

  1994cited by this paper
• Gene therapy for cancer using tumour-specific prodrug activation.

  1994cited by this paper
• Proximal cholangiocarcinoma: a multidisciplinary approach.

  1994cited by this paper
• Recent Advances in the Management of Cholangiocarcinomas

  1994cited by this paper
• In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.

  1993cited by this paper
• Definitive postoperative irradiation of bile duct carcinoma with charged particles and/or photons.

  1993cited by this paper
• Improved biliary stenting using a balloon catheter and the combined technique for difficult stenoses.

  1993cited by this paper
• What does the mean inactivation dose characterize?

  1993cited by this paper
• Bilateral internal biliary drainage of hilar cholangiocarcinoma with modified Gianturco Z stents inserted via a single percutaneous tract.

  1993cited by this paper
• A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase.

  1993cited by this paper
• The natural history of carcinoma of the bile duct in patients less than forty-five years of age.

  1992cited by this paper
• Experimental chemotherapy for xenograft cell lines of human bile duct and gall bladder cancers in nude mice

  1992cited by this paper
• Diffuse bile duct tumors: guidelines for management.

  1991cited by this paper
• Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis in sixty-four patients.

  1991cited by this paper
• Cholangiocarcinoma.

  1990cited by this paper
• The role of radiotherapy in the treatment of bile duct carcinoma.

  1990cited by this paper
• Results of Radiation Therapy in Carcinoma of the Proximal Bile Duct (Klatskin Tumor)

  1990cited by this paper
• Innovative techniques in radiation oncology.Clinical research programs to improve local and regional control in cancer

  1990cited by this paper
• Intraoperative radiation therapy for biliary tract carcinoma: results of a 5-year experience.

  1989cited by this paper
• Enhancement of radiation effects by acyclovir.

  1986cited by this paper
• The mean inactivation dose: experimental versus theoretical.

  1986cited by this paper
• Primary cancers of extrahepatic biliary passages.

  1984cited by this paper
• Mean inactivation dose: a useful concept for intercomparison of human cell survival curves.

  1984cited by this paper
• 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract.

  1984cited by this paper
• ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES.

  1965cited by this paper

• Progress of engineered bacteria for tumour therapy.

  2024cites this paper
• Structural characterization of an isocytosine-specific deaminase VCZ reveals its application potential in the anti-cancer therapy

  2023cites this paper
• The role of bacteria and its derived biomaterials in cancer radiotherapy

  2022cites this paper
• The recent progresses in shRNA-nanoparticle conjugate as a therapeutic approach.

  2019cites this paper
• Gene therapy in the treatment of human cancer

  2017cites this paper
• Synergistic Effect of Forbesione From Garcinia hanburyiin Combination with 5-Fluorouracil on Cholangiocarcinoma

  2017cites this paper
• Evaluation of a novel, suicide gene-armed measles vaccine virus for the treatment of cholangiocarcinoma

  2016cites this paper
• Expression of Ki-67, Bax and p73 in patients with hilar cholangiocarcinoma

  2014cites this paper
• Gene-Directed Enzyme Prodrug Therapy

  2014cites this paper
• A Novel Armed Oncolytic Measles Vaccine Virus for the Treatment of Cholangiocarcinoma

  2013influential citation
• Cancer Treatment with Gene Therapy and Radiation Therapy

  2013cites this paper
• Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cells

  2013cites this paper
• Emerging Implications of Nonmammalian Cytosine Deaminases on Cancer Therapeutics

  2012cites this paper
• Chapter seven--Cancer treatment with gene therapy and radiation therapy.

  2012cites this paper
• Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.

  2010cites this paper
• Cytosine Deaminase/5‐Fluorocytosine Molecular Cancer Chemotherapy

  2010cites this paper
• 71 – Molecular Targeted Therapy

  2010cites this paper
• The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat.

  2009cites this paper
• Prodrug cancer gene therapy.

  2008cites this paper
• Modified vaccinia virus Ankara as a vector for suicide gene therapy

  2008cites this paper
• Molecular chemotherapy of pancreatic cancer using novel mutant bacterial cytosine deaminase gene

  2008cites this paper
• Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors

  2007cites this paper
• Combination of Gene Therapy with Radiation

  2007cites this paper
• Solitary recurrence of hilar cholangiocarcinoma in a mediastinal lymph node two years after curative resection.

  2007cites this paper
• Suicide genes for cancer therapy.

  2007cites this paper
• Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma

  2007cites this paper
• Enhancing radiotherapy with genetically engineered viruses.

  2007cites this paper
• Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity

  2006cites this paper
• Radiosensitization by Gene Therapy

  2005cites this paper
• Gene therapy for cholangiocarcinoma

  2005cites this paper
• Cancer Gene Therapy

  2005cites this paper
• Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization.

  2005cites this paper
• Optimization of radiation controlled gene expression by adenoviral vectors in vitro

  2005cites this paper
• Suicide Gene Therapy for Pancreatic Cancer

  2004cites this paper
• STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells.

  2004cites this paper
• Genetic Alterations in Intrahepatic Cholangiocarcinoma as revealed by Degenerate Oligonucleotide Primed PCR-Comparative Genomic Hybridization

  2004cites this paper
• The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.

  2004cites this paper
• Gene expression imaging with radiolabeled peptides

  2004cites this paper
• Pancreatic Disease

  2004cites this paper
• Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells.

  2004cites this paper
• The tumor-selective viral protein apoptin effectively kills human biliary tract cancer cells

  2004cites this paper
• Imaging and therapy of tumors induced to express somatostatin receptor by gene transfer using radiolabeled peptides and single chain antibody constructs.

  2004cites this paper
• Combination with CD/5‐FC gene therapy enhances killing of human bladder‐cancer cells by radiation

  2003cites this paper
• Cancer Gene Therapy

  2003cites this paper
• Pre-operative radiochemotherapy of locally advanced rectal cancer.

  2003cites this paper
• Radiation Enhances the Anti-tumor Effects of Vaccinia-p53 Gene Therapy in Glioma

  2003cites this paper
• Effect of treatment sequence with radiotherapy and the antiestrogen EM 800 on the growth of ZR 75 1 human mammary carcinoma in nude mice

  2003cites this paper
• Prodrugs in genetic chemoradiotherapy.

  2003cites this paper
• Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)

  2003cites this paper
• Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.

  2003cites this paper
• Highly suppressible expression of single‐chain interleukin‐12 by doxycycline following adenoviral infection with a single‐vector Tet‐regulatory system

  2003cites this paper
• Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene.

  2003cites this paper
• Fusogenic membrane glycoproteins as a gene therapy for cancer.

  2003cites this paper
• Molecular approaches to chemo-radiotherapy.

  2002cites this paper
• Experimental Human Glioblastomas Deaminase / 5-Fluorocytosine Gene Therapy Is Effective for Intratumoral 5-Fluorouracil Produced by Cytosine Updated Version

  2002influential citation
• Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitro.

  2002cites this paper
• Chemotherapeutic dose intensification for treatment of malignant brain tumors: Recent developments and future directions

  2002cites this paper
• Combined radiation and gene therapy for brain tumors with adenovirus-mediated transfer of cytosine deaminase and uracil phosphoribosyltransferase genes

  2002cites this paper
• Development of a novel enzyme/prodrug system for hypoxia- and radiation-mediated gene therapy of cancer.

  2002cites this paper
• Application of Molecular Biology Studies to Gene Therapy Treatment Strategies

  2002cites this paper
• Strategies for Combining Gene Therapy with Ionizing Radiation to Improve Antitumor Efficacy

  2002cites this paper
• Oxic and anoxic enhancement of radiation-mediated toxicity by horseradish peroxidase/indole-3-acetic acid gene therapy

  2002cites this paper
• [Genetic therapy of cancer].

  2002cites this paper
• Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma.

  2002cites this paper
• Potential benefits of combining cytosine deaminase/5‐fluorocytosine gene therapy and irradiation for prostate cancer: Experimental study

  2002cites this paper
• Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.

  2002cites this paper
• Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.

  2002cites this paper
• Prostate cancer gene therapy and the role of radiation.

  2002cites this paper
• Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene.

  2001cites this paper
• Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives

  2001cites this paper
• Gene Therapy for the Treatment of Cancer

  2001cites this paper
• Selected Features of Nonendocrine Pancreatic Cancer

  2001cites this paper
• Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation.

  2001cites this paper
• Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross‐species color banding

  2001cites this paper
• Sensitization of prostate cancer cell lines to 5-fluorocytosine induced by adenoviral vector carrying a CD transcription unit.

  2001cites this paper
• Chirurgische Therapie von Karzinomen der extrahepatischen Gallenwege und der Gallenblase

  2001cites this paper
• Cancer gene therapy: developments to 2000

  2000cites this paper
• Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models

  2000cites this paper
• A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo.

  2000cites this paper
• Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.

  2000cites this paper
• Development of synthetic promoters for radiation-mediated gene therapy

  2000cites this paper
• In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus

  2000cites this paper
• The potential therapeutic gain of radiation-associated gene therapy with the suicide gene cytosine deaminase.

  2000cites this paper
• Gene transfer strategies for improving radiolabeled peptide imaging and therapy.

  2000cites this paper
• Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.

  2000cites this paper
• Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of Escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine

  2000cites this paper
• Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma

  2000cites this paper
• Strategies for enhancing viral-based gene therapy using ionizing radiation.

  1999cites this paper
• Effect of combined treatment with the pure antiestrogen EM-800 and radiotherapy on the growth of human ZR-75-1 breast cancer xenografts in nude mice.

  1999cites this paper
• Combined radiation and enzyme/prodrug treatment for head and neck cancer in an orthotopic animal model.

  1999cites this paper
• Gene therapy for cancer.

  1999cites this paper
• Enzyme/Prodrug Therapy for Head and Neck Cancer Using a Catalytically Superior Cytosine Deaminase

  1999cites this paper
• Gene therapy for cancer.

  1999cites this paper
• Nichtchirurgische/palliative Behandlung des zentralen Gallengangskarzinoms

  1999cites this paper
• Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts.

  1999cites this paper
• Adenovirus-mediated gene therapy of liver diseases.

  1999cites this paper
• Effects of the antiestrogen EM-800 (SCH 57050) and cyclophosphamide alone and in combination on growth of human ZR-75-1 breast cancer xenografts in nude mice.

  1999cites this paper
• Gene therapy for pancreatic and biliary malignancies.

  1999cites this paper
• Effect of Combined Treatment with the Pure Antiestrogen EM-800 and Radiotherapy on the Growth of Human ZR-751 Breast Cancer Xenografts in Nude Mice

  1999cites this paper
• Advances in cancer gene therapy

  1999cites this paper